Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 2, 2021CancersOpen Access

TP53 Combined Phenotype Score Is Associated with the Clinical Outcome of TP53-Mutated Myelodysplastic Syndromes

View Full Paper
Ask AI
Bookmark
Share

Authors

MYMariko YabeMemorial Sloan Kettering Cancer CenterAOAidana Z. OmarbekovaMHMeier HsuDartmouth College

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Yabe et al. (2021) studied this question.

synapsesocial.com/papers/6a867137e3ff5bf5642ed34ehttps://doi.org/10.3390/cancers13215502
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Clinical Effect of Point Mutations in Myelodysplastic Syndromes2011 · 1,642 citations
  2. 2TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups2019 · 266 citations
  3. 3Landscape of genetic lesions in 944 patients with myelodysplastic syndromes2013 · 1,558 citations